Jefferies raises Zymeworks price target to $52
Bullish analyst view, though the target change itself is modest and remains an analyst estimate.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Bullish analyst view, though the target change itself is modest and remains an analyst estimate.
What happened, with direct paths to the underlying reporting
Jefferies raised its ZYME price target to $52 from $50; the posted price was $28.22.
Target: $52
Posted price: $28.22
Analyst firm: Jefferies
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.